
Validea's guru fundamental report rates Lam Research Corp (LRCX), a large-cap semiconductor stock, at 100% using its Warren Buffett-inspired Patient Investor model. This top rating signifies LRCX's strong alignment with criteria for long-term, predictable profitability, low debt, and reasonable valuation, having passed all underlying fundamental tests including earnings predictability and free cash flow. Such a robust fundamental profile suggests a compelling long-term investment case for institutional consideration.
Lam Research Corp (LRCX) has achieved a perfect 100% rating based on Validea's Patient Investor model, which emulates the fundamental investment principles of Warren Buffett. This top-tier score signifies a strong alignment with criteria focused on long-term predictable profitability, low debt, and reasonable valuation, with scores above 90% indicating significant interest. The analysis confirms LRCX, a large-cap growth stock in the semiconductor industry, passed every one of the model's fundamental tests. These include critical measures of financial health and operational efficiency such as Earnings Predictability, Debt Service, Return on Equity, Return on Total Capital, and Free Cash Flow. Furthermore, the company's positive screening for Use of Retained Earnings and Share Repurchases suggests a strong and shareholder-friendly capital allocation policy, reinforcing its profile as a high-quality name according to this specific quantitative framework.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment